论文部分内容阅读
目的探究法莫替丁联合硫糖铝治疗急性胃炎的临床疗效。方法将本院2012年1月~2013年12月收治的120例急性胃炎患者按随机数字表法随机分为两组,治疗组60例采用法莫替丁联合口服硫糖铝治疗,对照组60例采用法莫替丁治疗,治疗5 d后对比两组疗效。结果治疗组总有效率98.3%,明显优于对照组的91.7%,组间差异有统计学意义(P<0.05)。两组均未发生严重不良反应。结论法莫替丁联合硫糖铝治疗急性胃炎优于单一用药,副作用少,值得临床进一步研究及推广应用。
Objective To investigate the clinical efficacy of famotidine combined with sucralfate in the treatment of acute gastritis. Methods A total of 120 patients with acute gastritis admitted from January 2012 to December 2013 in our hospital were randomly divided into two groups according to the random number table method. 60 cases in the treatment group were treated with famotidine combined with oral sucralfate, while the control group 60 Cases of famotidine treatment, after 5 days of treatment compared two groups curative effect. Results The total effective rate of the treatment group was 98.3%, which was significantly better than that of the control group (91.7%). The difference between the two groups was statistically significant (P <0.05). No serious adverse reactions occurred in both groups. Conclusions Famotidine combined with sucralfate is superior to monotherapy in the treatment of acute gastritis with fewer side effects and deserves further clinical study and application.